arrow
C

Clint A. Stalnecker

University of North Carolina at Chapel Hill
H指数:17
被引数:4,395

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Defining the MYC-regulated transcriptome and kinome that support KRAS- and ERK-dependent growth of pancreatic cancer

定义支持胰腺癌KRAS-和ERK依赖性生长的MYC调控转录组与激酶组

2025-09-300
PRE
Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer

胰腺癌中RAS-GTP抑制的肿瘤选择性活性

Nature
IF48.5
2024-04-080
OAAI
Resistance to RAS-GTP inhibition in models of pancreatic ductal adenocarcinoma arises downstream of RAS effectors

胰腺导管腺癌模型中对RAS-GTP抑制的抗性出现在RAS效应物的下游

2024-03-220
PRE
Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers
Science
IF45.8
2024-01-010
OA
Determining the ERK-regulated phosphoproteome driving KRAS-mutant cancer
Science
IF45.8
2024-01-010
OA
TEAD Inhibition Overcomes YAP1/TAZ-Driven Primary and Acquired Resistance to KRASG12C Inhibitors

TEAD抑制克服了YAP1/TAZ驱动的对KRASG12C抑制剂的原发性和获得性抗性

2023-11-0718
OA
Determination of KRAS- and ERK-regulated phosphoproteomes in KRAS-mutant cancers
2023-05-010
PRE
Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic Cancer

联合CDK4/6抑制剂治疗KRAS突变型胰腺癌

2022-11-0857
OA